Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Non-Current Debt (2016 - 2025)

Historic Non-Current Debt for Integra Lifesciences Holdings (IART) over the last 17 years, with Q3 2025 value amounting to $1.7 billion.

  • Integra Lifesciences Holdings' Non-Current Debt rose 5091.96% to $1.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year increase of 5091.96%. This contributed to the annual value of $1.1 billion for FY2024, which is 3177.88% up from last year.
  • As of Q3 2025, Integra Lifesciences Holdings' Non-Current Debt stood at $1.7 billion, which was up 5091.96% from $1.1 billion recorded in Q2 2025.
  • In the past 5 years, Integra Lifesciences Holdings' Non-Current Debt registered a high of $1.7 billion during Q3 2025, and its lowest value of $733.1 million during Q4 2022.
  • Over the past 5 years, Integra Lifesciences Holdings' median Non-Current Debt value was $825.6 million (recorded in 2023), while the average stood at $962.8 million.
  • Its Non-Current Debt has fluctuated over the past 5 years, first tumbled by 1827.72% in 2021, then skyrocketed by 5225.21% in 2024.
  • Over the past 5 years, Integra Lifesciences Holdings' Non-Current Debt (Quarter) stood at $824.3 million in 2021, then dropped by 11.05% to $733.1 million in 2022, then rose by 12.61% to $825.6 million in 2023, then skyrocketed by 31.78% to $1.1 billion in 2024, then skyrocketed by 57.08% to $1.7 billion in 2025.
  • Its Non-Current Debt was $1.7 billion in Q3 2025, compared to $1.1 billion in Q2 2025 and $1.1 billion in Q1 2025.